2023-12-01 15:22:45 ET
DENVER, Colo., Dec 1, 2023 ( www.247marketnews.com )- we reported that NexImmune (NASDAQ: NEXI) shares were blasting off, in this morningâ€™s premarket trading. We commented that it hasnâ€™t published news since before November, but somehow todayâ€™s volume would surely set a 52-week high, so it was set to take out multiple resistance levels along the way.
Theat fishy stench grew stronger when Nasdaq issued NexImmune a T-12 Halt.
Neximmune is now trading again after filing a â€œFailure to Satisfy Listing Rule â€“ Form 8-Kâ€ this afternoon, confirming that NexImmune received notice from Nasdaqâ€™s Listing Qualifications Department, on November 30, 2023, notifying Neximmune that based on Nasdaqâ€™s review of Neximmune and pursuant to Nasdaq Listing Rule 5101, Nasdaq believes that Neximmune â€¦
For further details see:
This article is for the purposes of solicitation subscriptions for this website. This website expects to generate new advertisement revenue resulting from the distribution of this article. The amount of which is unknown at this time. This website or it’s authors do not own any shares of NexImmune Inc. (NEXI) and does not buy, sell, or trade any shares of (NEXI). This article does not provide a professional analysis of a (NEXI) financial position. (NEXI) financial position and all other information regarding the featured Company should be verified directly with (NEXI). Please read our full disclaimer for more detailed information.